What is it about?
This paper describes the repositioning of known drugs using computational methods. We used ligand and sctructure based virtual screening approaches. This furnished us the identification of 7 drugs approved for other therapies which could have potential to also treat COVID-19.
Photo by Martin Sanchez on Unsplash
Why is it important?
Finding drug-based therapies to treat COVID-19 would increase the success of preventing symptoms, reduce the number of deaths, and combating this pandemic that represents a global health issue.
Read the Original
This page is a summary of: Identification of known drugs as potential SARS-CoV-2 Mpro inhibitors using ligand- and structure-based virtual screening, Future Medicinal Chemistry, June 2021, Future Science, DOI: 10.4155/fmc-2021-0025.
You can read the full text:
The following have contributed to this page